<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0550">
 <label>110</label>
 <element-citation publication-type="journal" id="rf0530">
  <person-group person-group-type="author">
   <name>
    <surname>Agostini</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Andres</surname>
    <given-names>E.L.</given-names>
   </name>
   <name>
    <surname>Sims</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Graham</surname>
    <given-names>R.L.</given-names>
   </name>
   <name>
    <surname>Sheahan</surname>
    <given-names>T.P.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>E.C.</given-names>
   </name>
   <name>
    <surname>Case</surname>
    <given-names>J.B.</given-names>
   </name>
   <name>
    <surname>Feng</surname>
    <given-names>J.Y.</given-names>
   </name>
   <name>
    <surname>Jordan</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ray</surname>
    <given-names>A.S.</given-names>
   </name>
  </person-group>
  <article-title>Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease</article-title>
  <source>MBio</source>
  <volume>9</volume>
  <issue>2</issue>
  <year>2018</year>
  <comment>May 2. (e00221-18)</comment>
 </element-citation>
</ref>
